Biotech Investing BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 4h
Biotech Investing BriaCell to Present Bria-OTS+ Preclinical Data at SITC 2025 Annual Meeting 03 October
Biotech Investing BriaCell's Bria-OTS+ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal 26 August
